Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong

Abstract Recent studies have reported numerous predictors for adverse outcomes in COVID-19 disease. However, there have been few simple clinical risk scores available for prompt risk stratification. The objective is to develop a simple risk score for predicting severe COVID-19 disease using territor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jiandong Zhou, Sharen Lee, Xiansong Wang, Yi Li, William Ka Kei Wu, Tong Liu, Zhidong Cao, Daniel Dajun Zeng, Keith Sai Kit Leung, Abraham Ka Chung Wai, Ian Chi Kei Wong, Bernard Man Yung Cheung, Qingpeng Zhang, Gary Tse
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/9bbff64d31ad4c4d921fa169b2fe5fc7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9bbff64d31ad4c4d921fa169b2fe5fc7
record_format dspace
spelling oai:doaj.org-article:9bbff64d31ad4c4d921fa169b2fe5fc72021-12-02T14:37:29ZDevelopment of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong10.1038/s41746-021-00433-42398-6352https://doaj.org/article/9bbff64d31ad4c4d921fa169b2fe5fc72021-04-01T00:00:00Zhttps://doi.org/10.1038/s41746-021-00433-4https://doaj.org/toc/2398-6352Abstract Recent studies have reported numerous predictors for adverse outcomes in COVID-19 disease. However, there have been few simple clinical risk scores available for prompt risk stratification. The objective is to develop a simple risk score for predicting severe COVID-19 disease using territory-wide data based on simple clinical and laboratory variables. Consecutive patients admitted to Hong Kong’s public hospitals between 1 January and 22 August 2020 and diagnosed with COVID-19, as confirmed by RT-PCR, were included. The primary outcome was composite intensive care unit admission, need for intubation or death with follow-up until 8 September 2020. An external independent cohort from Wuhan was used for model validation. COVID-19 testing was performed in 237,493 patients and 4442 patients (median age 44.8 years old, 95% confidence interval (CI): [28.9, 60.8]); 50% males) were tested positive. Of these, 209 patients (4.8%) met the primary outcome. A risk score including the following components was derived from Cox regression: gender, age, diabetes mellitus, hypertension, atrial fibrillation, heart failure, ischemic heart disease, peripheral vascular disease, stroke, dementia, liver diseases, gastrointestinal bleeding, cancer, increases in neutrophil count, potassium, urea, creatinine, aspartate transaminase, alanine transaminase, bilirubin, D-dimer, high sensitive troponin-I, lactate dehydrogenase, activated partial thromboplastin time, prothrombin time, and C-reactive protein, as well as decreases in lymphocyte count, platelet, hematocrit, albumin, sodium, low-density lipoprotein, high-density lipoprotein, cholesterol, glucose, and base excess. The model based on test results taken on the day of admission demonstrated an excellent predictive value. Incorporation of test results on successive time points did not further improve risk prediction. The derived score system was evaluated with out-of-sample five-cross-validation (AUC: 0.86, 95% CI: 0.82–0.91) and external validation (N = 202, AUC: 0.89, 95% CI: 0.85–0.93). A simple clinical score accurately predicted severe COVID-19 disease, even without including symptoms, blood pressure or oxygen status on presentation, or chest radiograph results.Jiandong ZhouSharen LeeXiansong WangYi LiWilliam Ka Kei WuTong LiuZhidong CaoDaniel Dajun ZengKeith Sai Kit LeungAbraham Ka Chung WaiIan Chi Kei WongBernard Man Yung CheungQingpeng ZhangGary TseNature PortfolioarticleComputer applications to medicine. Medical informaticsR858-859.7ENnpj Digital Medicine, Vol 4, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Computer applications to medicine. Medical informatics
R858-859.7
spellingShingle Computer applications to medicine. Medical informatics
R858-859.7
Jiandong Zhou
Sharen Lee
Xiansong Wang
Yi Li
William Ka Kei Wu
Tong Liu
Zhidong Cao
Daniel Dajun Zeng
Keith Sai Kit Leung
Abraham Ka Chung Wai
Ian Chi Kei Wong
Bernard Man Yung Cheung
Qingpeng Zhang
Gary Tse
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong
description Abstract Recent studies have reported numerous predictors for adverse outcomes in COVID-19 disease. However, there have been few simple clinical risk scores available for prompt risk stratification. The objective is to develop a simple risk score for predicting severe COVID-19 disease using territory-wide data based on simple clinical and laboratory variables. Consecutive patients admitted to Hong Kong’s public hospitals between 1 January and 22 August 2020 and diagnosed with COVID-19, as confirmed by RT-PCR, were included. The primary outcome was composite intensive care unit admission, need for intubation or death with follow-up until 8 September 2020. An external independent cohort from Wuhan was used for model validation. COVID-19 testing was performed in 237,493 patients and 4442 patients (median age 44.8 years old, 95% confidence interval (CI): [28.9, 60.8]); 50% males) were tested positive. Of these, 209 patients (4.8%) met the primary outcome. A risk score including the following components was derived from Cox regression: gender, age, diabetes mellitus, hypertension, atrial fibrillation, heart failure, ischemic heart disease, peripheral vascular disease, stroke, dementia, liver diseases, gastrointestinal bleeding, cancer, increases in neutrophil count, potassium, urea, creatinine, aspartate transaminase, alanine transaminase, bilirubin, D-dimer, high sensitive troponin-I, lactate dehydrogenase, activated partial thromboplastin time, prothrombin time, and C-reactive protein, as well as decreases in lymphocyte count, platelet, hematocrit, albumin, sodium, low-density lipoprotein, high-density lipoprotein, cholesterol, glucose, and base excess. The model based on test results taken on the day of admission demonstrated an excellent predictive value. Incorporation of test results on successive time points did not further improve risk prediction. The derived score system was evaluated with out-of-sample five-cross-validation (AUC: 0.86, 95% CI: 0.82–0.91) and external validation (N = 202, AUC: 0.89, 95% CI: 0.85–0.93). A simple clinical score accurately predicted severe COVID-19 disease, even without including symptoms, blood pressure or oxygen status on presentation, or chest radiograph results.
format article
author Jiandong Zhou
Sharen Lee
Xiansong Wang
Yi Li
William Ka Kei Wu
Tong Liu
Zhidong Cao
Daniel Dajun Zeng
Keith Sai Kit Leung
Abraham Ka Chung Wai
Ian Chi Kei Wong
Bernard Man Yung Cheung
Qingpeng Zhang
Gary Tse
author_facet Jiandong Zhou
Sharen Lee
Xiansong Wang
Yi Li
William Ka Kei Wu
Tong Liu
Zhidong Cao
Daniel Dajun Zeng
Keith Sai Kit Leung
Abraham Ka Chung Wai
Ian Chi Kei Wong
Bernard Man Yung Cheung
Qingpeng Zhang
Gary Tse
author_sort Jiandong Zhou
title Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong
title_short Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong
title_full Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong
title_fullStr Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong
title_full_unstemmed Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong
title_sort development of a multivariable prediction model for severe covid-19 disease: a population-based study from hong kong
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9bbff64d31ad4c4d921fa169b2fe5fc7
work_keys_str_mv AT jiandongzhou developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT sharenlee developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT xiansongwang developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT yili developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT williamkakeiwu developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT tongliu developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT zhidongcao developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT danieldajunzeng developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT keithsaikitleung developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT abrahamkachungwai developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT ianchikeiwong developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT bernardmanyungcheung developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT qingpengzhang developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
AT garytse developmentofamultivariablepredictionmodelforseverecovid19diseaseapopulationbasedstudyfromhongkong
_version_ 1718391021976420352